Investors

We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians.

Presentations & Events

More events are coming soon.

Latest Earnings

Quarterly Earnings Results will become available soon.

Media Contacts

Dan Budwick

1AB

973-271-6085